The Mighty Logo

What's the 'Best' Antidepressant? What a New Study Really Says

Feel less alone
Get our helpful emails

Finding an antidepressant can feel like a guessing game, and it often asks you to keep going when you feel your most tired. A big new study just tried to bring some clarity. Here is the short answer: no single antidepressant works best for everyone, but the study did find three medicines that beat a common benchmark over the long term. Below you will find what it found, what it cannot tell you, and how to bring it into a conversation with your own doctor.

Quick Answers

  • What’s the “best” antidepressant? No single medicine works best for everyone. A new study in The Lancet Psychiatry ranked 20 antidepressants for long-term results. It found that escitalopram (Lexapro), agomelatine, and duloxetine (Cymbalta) were more effective than fluoxetine (Prozac) at helping people get well and stay well.
  • Does this mean you should switch? No. If your medicine works and you tolerate it, the study gives you no reason to change. The study compares groups of people, and it cannot tell you what suits your body, your history, or your life.
  • Why does the “best” medicine differ from person to person? Side effects, other health conditions, other medicines, past responses, pregnancy plans, cost and access all shape the choice. Your doctor weighs those with you.

Why “Best Antidepressant” Feels So Loaded

Antidepressants help many people. They also come with real trade-offs, and the road to the right one can feel long. You might wait weeks to know whether a medicine helps. You might cope with side effects while you wait. You might start over with a new medicine and feel the weight of that restart.

Many people also carry quiet worries: that they take the “wrong” one, that a better one waits untried, or that their doctor chose a weaker option. A headline that promises “the best antidepressant” can stir all of that up. You deserve a clear picture instead of a cliffhanger, so the next sections walk through it.

What the New Study Did

In November 2026, a research team led by Radboud University Medical Center in the Netherlands published a systematic review and network meta-analysis in The Lancet Psychiatry. The paper’s title is “Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depressive disorder.”

Here is what those terms mean in plain language:

  • Systematic review: The team searched for all eligible studies rather than selecting a few favorites.
  • Network meta-analysis: The team combined results from many trials and used statistics to compare medicines that never met head to head in a single trial. This method lets researchers rank many medicines at once.
  • Long-term treatment: The team focused on how people do over months, not only in the first few weeks.

According to the study details released by the research team’s university, the analysis included 115 randomized clinical trials with more than 30,000 participants. The team compared 20 antidepressants with each other and with fluoxetine, which served as the reference point. The main goal was what the team called sustained response, which means people get well and stay well.

What the Study Found

The team reported that three medicines did better than fluoxetine for long-term results:

  • Escitalopram (Lexapro): An SSRI that doctors already prescribe widely. The lead researcher described it as appearing to be the most effective SSRI for long-term use.
  • Agomelatine: A medicine used in parts of the world, including Europe. The research team noted a risk of liver problems as a possible side effect.
  • Duloxetine (Cymbalta): An SNRI that doctors prescribe less often as a first choice.

Agomelatine is not approved for use in the United States. Check with a pharmacist or prescriber about what is available where you live.

The research team has also said the findings do not mean everyone with severe depression should receive escitalopram. The balance between benefits and side effects differs from person to person, so doctors and patients need to make the choice together.

How to Read These Results Without Spiraling

A ranking can sound more final than it is. Here are some things to keep in mind.

1. “Better Than Fluoxetine” Does Not Mean “Better Than Everything You Take”

The study used fluoxetine as its yardstick. Being ahead of fluoxetine indicates how a medicine compares with that drug. It does not tell you how it compares with the medicine you take now.

2. A Group Average Is Not a Personal Forecast

A network meta-analysis averages results across thousands of people. Your own brain, body, and life are not an average. A medicine that ranks in the middle of the list can still be the best fit for you.

3. Indirect Comparisons Carry Uncertainty

Network meta-analyses estimate some comparisons indirectly. Two medicines that never faced each other in a trial get compared through a shared link, such as fluoxetine. That approach is powerful, and it also means rankings are only as strong as the trials underneath.

4. Trial Length and Trial Quality Matter

Trials last from weeks to a couple of years, and their quality varies. The longer and sturdier the trial, the more weight its findings carry. Treat the ranking as an important data point, not the last word.

5. Doctors Weigh More Than Effectiveness

Your doctor also thinks about side effects, other conditions, other medicines, pregnancy, age, cost, and how you responded before. Those factors can outweigh a small difference in a group ranking.

What Other Recent Research Adds

Side Effects Differ a Lot From Drug to Drug

A 2025 systematic review and network meta-analysis in The Lancet looked at the physical side effects of antidepressants. An international team analyzed 151 randomized trials plus 17 government regulatory reports, covering 58,534 participants and 30 antidepressants. Most trials lasted about eight weeks.

Here are some of the findings, as summarized in coverage of the paper:

  • Weight: Agomelatine produced the most weight loss, about 2.4 kg more than placebo. Amitriptyline and maprotiline produced the most weight gain, up to about 1.8 kg.
  • Heart rate: Nortriptyline increased heart rate by nearly 14 beats per minute, while fluvoxamine decreased it by about 8 beats per minute.
  • Blood pressure: Amitriptyline raised the top number by almost 5 points, while nortriptyline lowered it by more than 6.
  • Cholesterol, blood sugar, and liver tests: A handful of medicines, including duloxetine, venlafaxine, and desvenlafaxine, raised cholesterol levels or other lab values. Duloxetine also raised blood sugar. Those liver test changes were not high enough to pose an immediate threat for most people.
  • Heart rhythm: No antidepressant changed heart rhythm measures to a worrying degree during the trials.
  • Mood link: In depression trials, improvement in mood did not track with changes in weight, cholesterol or blood sugar.

The authors noted limits. Most trials lasted only about eight weeks, so long-term effects remain uncertain. Participants tended to be younger and healthier than many real-world patients, and many trials excluded older adults and people with other health conditions.

The takeaway for you: if side effects trouble you, that matters, and it is a reason to talk with your prescriber. Different medicines carry different profiles. You are not imagining the differences.

Stopping Safely Is Part of the Plan

If you want to come off an antidepressant, a 2026 systematic review and network meta-analysis in The Lancet Psychiatry offers useful news. The team analyzed 76 randomized trials with 17,379 adults whose depression had clinically remitted. They compared several ways of stopping.

According to the summary:

  • A slow taper with structured psychological support worked about as well as staying on the usual dose for preventing relapse.
  • It worked significantly better than stopping abruptly or quickly.
  • About five people needed to use the slow, supported approach to prevent one extra relapse, and the certainty of the evidence was moderate.

The summary did not describe how long the tapers lasted or what the psychological support looked like. Treat this as a reason to ask your prescriber about a plan, not as a schedule to follow on your own. Stopping suddenly can bring withdrawal symptoms and raise the risk of relapse, and a clinician can build a gradual plan with you.

What “Best” Might Mean for You

For you, the “best” antidepressant might be the one that:

  • Eases your symptoms enough that you feel more like yourself
  • Comes with side effects you can live with
  • Fits your other health conditions and medicines
  • Fits your plans for pregnancy or breastfeeding, if those apply
  • Fits your budget and your pharmacy
  • Matches what has worked for close relatives, which sometimes offers a clue
  • Suits your sleep, appetite, energy and anxiety patterns

A medicine that tops a ranking and makes you feel numb, sleepless or unwell is not the best one for you. A medicine that sits mid-pack and gives you your life back is.

Questions to Bring to Your Next Appointment

Bring any of these, in any order:

  1. What goals does this medicine aim for, and how will we know it works?
  2. Which side effects deserve attention in the first weeks, and which ones need a call?
  3. How long should the trial period last before deciding it is not working?
  4. If this one does not help, what is the next step?
  5. Do other medicines, supplements or health conditions change the choice?
  6. Does physical health need monitoring, such as weight, blood pressure or blood tests?
  7. If stopping becomes a goal someday, what is the plan?
  8. What changes with pregnancy or plans for pregnancy?
  9. What does this cost, and are there cheaper options?

Support for Different Situations

If You Feel Anxious About Your Current Medicine

One headline does not mean your medicine is the wrong one. Many factors beyond a ranking decide what works for you. If you feel unsure, write down your questions and bring them to your prescriber. In the United States, you can call or text 988 at any time if worry feels heavy or you feel unsafe.

If Your Medicine Is Working

Good news: you have already done the hard part. The study gives you no reason to switch. If it works and you tolerate it, you can keep going and keep checking in with your prescriber.

If You Are Still Searching for the Right One

Trying more than one medicine is common, and it does not mean you failed. Keep a short daily note on mood, sleep, appetite, side effects, and anything that surprises you. That note helps your prescriber see patterns.

If Side Effects Are Hard

You deserve a plan, not a lecture. Tell your prescriber what bothers you and when it started. The 2025 Lancet review above shows that side-effect profiles vary widely across medicines, which gives you and your prescriber room to look for a better fit.

If You Have Other Health Conditions

Heart disease, diabetes, liver problems, seizure disorders and bipolar disorder can all change which antidepressant is safe or suitable. Tell every clinician about every condition, and do not stop or switch on your own.

If You Are Pregnant, Planning Pregnancy or Breastfeeding

Do not stop your medicine suddenly. Depression and its treatment both matter in pregnancy, and the right plan depends on your health history. Talk with your prescriber and your obstetric provider together.

If You Are Under 25

The U.S. Food and Drug Administration requires a boxed warning on antidepressants about a higher risk of suicidal thoughts in children, teens and young adults, especially early in treatment or after dose changes. Young people and their families benefit from frequent check-ins during the first weeks.

If You Are Older

Trial participants were often younger and healthier, as noted in the 2025 Lancet review. Ask your prescriber how your age, other medicines and conditions affect the choice and the dose.

If You Are Autistic, Sensory-Sensitive or Neurodivergent

Medication effects can feel stronger or different when your senses and body signals are running high. Say so. Describe sensations in your own words, and ask your prescriber to start low and check in often.

If Cost or Access Limits Your Options

Ask about generic versions, pharmacy discount programs, patient assistance programs, and community clinics. If a ranked medicine is not available where you live, another option may work just as well for you.

If You Worry About Dependence or Withdrawal

Antidepressants differ from addictive substances, and stopping can still cause withdrawal-like symptoms for some people. A gradual, supported plan lowers that risk. Do not stop on your own.

When to Seek Medical Care

Call your prescriber soon if you notice:

  • Your mood stays low or worsens after several weeks on a medicine
  • Side effects make daily life hard, such as severe nausea, sleep loss, restlessness, sexual side effects or heavy sedation
  • New or worse anxiety, agitation or irritability
  • Symptoms that appear when you miss doses
  • You want to switch, stop or change a dose

Get urgent care or call emergency services if you notice:

  • Thoughts of harming yourself or ending your life, or thoughts that feel different or stronger after a medicine change
  • A very high mood, little need for sleep, racing thoughts or reckless behavior, which can signal mania
  • Fever, sweating, shaking, severe muscle stiffness, fast heartbeat, and confusion, which can signal serotonin syndrome
  • Swelling of the face or throat, trouble breathing, or a severe rash
  • Yellow skin or eyes, dark urine, or severe stomach pain
  • A seizure or fainting

If emotional distress or hopelessness comes up while you read about your health, you can call or text 988 in the United States to reach the Suicide and Crisis Lifeline at any hour.

A Comforting Note for Anyone Feeling Anxious About This

If this topic stirred up worry, take a breath. A ranking from a study describes groups of people. It does not describe you, and it does not mean you chose wrong. Searching for the right medicine takes patience, and needing more than one try says nothing bad about you.

Whatever your situation, you do not need to figure this out alone. Your prescriber, your therapist, your family and your community can each hold part of the load. Asking questions, noticing how you feel and speaking up about what helps and what does not all count as strength.

Frequently Asked Questions

What is the best antidepressant according to the new study?

The study found that escitalopram, agomelatine, and duloxetine were more effective than fluoxetine for long-term outcomes. That finding describes group averages and does not apply to every person.

Should you switch to escitalopram because of this study?

No. If your medicine works and you tolerate it, the study gives you no reason to switch. Talk with your prescriber before you change anything.

What does “sustained response” mean?

It means getting better and staying better over time, instead of improving briefly and then slipping back. The study focused on that long-term picture.

Why is agomelatine not available everywhere?

Regulators in different countries approve medicines separately, and agomelatine is not approved in the United States. Ask a pharmacist or prescriber what you can get where you live.

Do antidepressants cause weight gain?

It depends on the medicine. A large 2025 review found that some, like amitriptyline, tended to cause weight gain, while agomelatine tended to cause weight loss. Many trials lasted only about eight weeks, so longer-term effects remain uncertain.

How do you stop an antidepressant safely?

Talk with your prescriber first. A 2026 review found that a slow taper with psychological support protected against relapse about as well as staying on the usual dose, and it worked better than stopping quickly.

When should you see a doctor about your antidepressant?

See your prescriber if your mood does not improve, if side effects make daily life hard, or if you want to change or stop. Seek urgent care for thoughts of self-harm, signs of mania, or symptoms of serotonin syndrome, and call or text 988 in the United States if you feel unsafe.

Photo by SHVETS production / pexels
Originally published: November 16, 2026
Want more of The Mighty?
You can find even more stories on our Home page. There, you’ll also find thoughts and questions by our community.
Take Me Home